Consumables

Tiny antibody found to neutralise Hendra and Nipah viruses

09 July, 2025

There are no approved human vaccines for either disease, nor are there any known cures — but with the discovery of the new nanobody, that could all be about to change.


Cayman Chemical Bio-Active Lipid I Screening Library (96-Well)

08 July, 2025 | Supplied by: Sapphire Bioscience

Cayman Chemical's Bio-Active Lipid I Screening Library consists of 13 plates and contains more than 800 compounds in a 96-well Matrix tube rack format as 1 mM stocks in DMSO.


Echelon Biosciences ionisable lipids

04 July, 2025 | Supplied by: Sapphire Bioscience

Echelon Biosciences' ionisable lipids are the key components of lipid nanoparticles (LNPs) and have garnered intense interest due to their successful use in mRNA-based vaccines and other genetic therapies.


Proteintech anti-IgG VHH beads

02 July, 2025 | Supplied by: United Bioresearch Products Pty Ltd

Optimised for targeted precision and clean results, Proteintech's VHH-based beads are designed to redefine specificity and purity in immunoprecipitation, offering species-specific IgG binding and no Protein A or G contamination.


BioStatus CyTRAK Orange fluorescent dye

02 July, 2025 | Supplied by: Sapphire Bioscience

BioStatus's CyTRAK Orange is a novel fluorescent dye that preferentially stains the nucleus but also defines the cytoplasmic area in both live and fixed preparations.


Llama antibodies open door to future coronavirus protection

24 June, 2025

Researchers have discovered a novel class of small antibodies that are strongly protective against a wide range of SARS coronaviruses, including SARS-CoV-1 and numerous SARS-CoV-2 variants.


Bio-Rad Laboratories anti-idiotypic antibodies and Human IgM-FcSpyCatcher reagent

19 June, 2025 | Supplied by: Bio-Rad Laboratories Pty Ltd

Bio-Rad Laboratories has extended its range of recombinant monoclonal anti-idiotypic antibodies with the introduction of antibodies specific to pertuzumab (Perjeta), guselkumab (Tremfya), canakinumab (Ilaris), belimumab (Benlysta) and the bispecific drug emicizumab (Hemlibra).


ProSci Incorporated apoptosis antibodies

05 June, 2025 | Supplied by: Sapphire Bioscience

ProSci Incorporated provides an extensive catalogue of apoptotic antibodies including death receptors (DR4, DR5), Bcl-2 family member proteins (Bad, Bax, Bim, Puma), caspase family proteins, p53 signalling pathway, and apoptosis regulatory molecules and enzymes.


TdB Labs polysaccharides

03 June, 2025 | Supplied by: Sapphire Bioscience

TdB Labs' polysaccharide portfolio consists of both fluorescent and non-fluorescent polysaccharide derivatives.


AI predicts bacteria's resistance to cleaning agents

02 June, 2025

With DNA data and machine learning, accurate bacterial resistance predictions can be made in minutes.


Cayman Chemical Epigenetics Screening Library (96-Well)

02 June, 2025 | Supplied by: Sapphire Bioscience

The Cayman Chemical Epigenetics Screening Library (96-Well) is a compound library that is intended for screening a variety of epigenetic compounds.


Super-strong antibodies developed for cancer treatment

16 May, 2025

Scientists discovered that their antibody prototype, which was more rigid, was able to trigger a stronger response from the immune system compared to those made by our bodies.


Cayman Chemical Kinase Screening Library (96-Well)

09 May, 2025 | Supplied by: Sapphire Bioscience

Cayman Chemical's Kinase Screening Library (96-Well) consists of two plates and contains approximately 160 carefully chosen selective and non-selective kinase inhibitors in a 96-well Matrix tube rack format as 10 mM stock solutions in DMSO.


Newly created antivenom protects against 19 deadly snakes

06 May, 2025

By using antibodies from a human donor with a self-induced hyper-immunity to snake venom, US researchers claim to have developed the most broadly effective antivenom to date.


AdipoGen Life Sciences GLP-1, GIP and GCG receptor agonists

02 May, 2025 | Supplied by: Sapphire Bioscience

AdipoGen's range of GLP-1, GIP and GCG receptor agonists includes Liraglutide, Retatrutide, Semaglutide, Tirzapatide, Cagrillintide, DMB, Mazdutide and Survodutide.


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd